Trial Profile
Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase 1
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Allopregnanolone (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2018 New trial record